Arquivos do dia: Junho 16, 2022
Seguimento de longo prazo de estudo randomizado | Craniectomia descompressiva vs. cuidado médico padrão para pacientes com hipertensão intracraniana traumática.
16 Jun, 2022 | 14:03hEvaluation of Outcomes Among Patients With Traumatic Intracranial Hypertension Treated With Decompressive Craniectomy vs Standard Medical Care at 24 Months: A Secondary Analysis of the RESCUEicp Randomized Clinical Trial – JAMA Neurology (gratuito por tempo limitado)
Estudo original: Trial of Decompressive Craniectomy for Traumatic Intracranial Hypertension – New England Journal of Medicine
Conteúdos relacionados:
The Current Status of Decompressive Craniectomy in Traumatic Brain Injury – Current Trauma Reports
Comentário no Twitter
In this study, at 24 months, patients with posttraumatic refractory intracranial hypertension managed with a decompressive craniectomy had a sustained mortality reduction and higher rates of vegetative state, severe disability, and moderate disability. https://t.co/I8GqG885jh
— JAMA Neurology (@JAMANeuro) June 9, 2022
Outro estudo sugere que a variante Ômicron está associada com risco reduzido de síndrome inflamatória multissistêmica em crianças em comparação a variantes anteriores do SARS-CoV-2.
16 Jun, 2022 | 14:01hEstudo relacionado: Severity and Incidence of Multisystem Inflammatory Syndrome in Children During 3 SARS-CoV-2 Pandemic Waves in Israel – JAMA E Commentary: Kids’ COVID syndrome—MIS-C—less severe in Omicron – CIDRAP
Comentário no Twitter
Study found that the risk of multisystem inflammatory syndrome in children (MIS-C) following SARS-CoV-2 infection during the #Omicron wave substantially lower compared to previous #SARSCoV2 variants. https://t.co/GYrz9XA72Z
— JAMA Pediatrics (@JAMAPediatrics) June 8, 2022
Estudo randomizado | Suplementação de ácido graxo ômega 3 de origem marinha não reduz a incidência de olho seco em adultos saudáveis.
16 Jun, 2022 | 14:00hEfficacy of Marine ω-3 Fatty Acid Supplementation vs Placebo in Reducing Incidence of Dry Eye Disease in Healthy US Adults: A Randomized Clinical Trial – JAMA Ophthalmology (gratuito por tempo limitado)
Comentário convidado: Another Disappointment for ω-3 Fatty Acid and Dry Eye Disease – JAMA Ophthalmology (gratuito por tempo limitado)
Comentário no Twitter
In this randomized clinical trial, daily supplementation with marine omega-3 fatty acids (1 gram) for a median of 5.3 years had no significant effect on the incidence of diagnosed #dryeyedisease (DED) or reported DED symptoms. https://t.co/iTBONh6CZK
— JAMAOphthalmology (@JAMAOphth) June 9, 2022
Estudo de coorte | Desfechos de neurodesenvolvimento em 1 ano em bebês de mães com teste positivo para SARS-CoV-2 durante a gestação.
16 Jun, 2022 | 13:58hComentários:
Comentário no Twitter
This cohort study of #SARSCoV2 exposure in utero found preliminary evidence that maternal SARS-CoV-2 may be associated with neurodevelopmental sequelae in some offspring. https://t.co/dYdoJbNOdl
— JAMA Network Open (@JAMANetworkOpen) June 9, 2022
Revisão | O impacto e os riscos do surgimento de complicações do diabetes melito.
16 Jun, 2022 | 13:56hThe burden and risks of emerging complications of diabetes mellitus – Nature Reviews Endocrinology
Comentário no Twitter
New content online: The burden and risks of emerging complications of diabetes mellitus https://t.co/mWcYa7TsKz
— Nature Reviews Endocrinology (@NatureRevEndo) June 6, 2022
M-A | Ocorrência e potencial de transmissão de infecções por SARS-CoV-2 assintomáticas e pré-sintomáticas.
16 Jun, 2022 | 13:55hDiretriz | Triagem e momento cirúrgicos em pacientes com COVID submetidos a cirurgia torácica.
16 Jun, 2022 | 13:54hRevisão | Fisiopatologia e mecanismo da COVID longa.
16 Jun, 2022 | 13:52hPathophysiology and mechanism of long COVID: a comprehensive review – Annals of Medicine
[Preprint] Maior estudo para obter dados sobre COVID longa identifica uma ampla lista de diagnósticos.
16 Jun, 2022 | 13:51hComentário do estudo: Largest study to date on long COVID identifies a broad list of diagnoses – News Medical
Comentário no Twitter
🚨 The arguably largest #LongCovid study to date with millions of participants shows the increased risk of various symptoms after infection and the risk of having to take medications. https://t.co/DSvRcKVKIs pic.twitter.com/uUQxK1VQLv
— Jonas R. Kunst (@KunstJonas) May 23, 2022
Diretriz sobre o tratamento de infecções no pé relacionadas ao diabetes.
16 Jun, 2022 | 13:49hConteúdos relacionados: